News | Contrast Media | January 17, 2020

Voluntary Dismissal of Chuck Norris Gadolinium Case Involving Bracco

The lawsuit alleging injury from the company's MR contrast agent has been closed

Gadolinium based contrast dye in brain MRI

Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.

January 17, 2020 — Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., one of the world’s leading companies in the diagnostic imaging business, does not comment on pending litigations per its corporate policy. However, Bracco is pleased to announce today that the lawsuit filed by Chuck and Gena Norris, in which Mrs. Norris alleged injury from Bracco’s magnetic resonance (MR) contrast agent MultiHance (gadobenate dimeglumine) injection, 529 mg/mL, has been voluntarily dismissed by the Norris couple. The case is now closed. The decision to dismiss the lawsuit was entirely that of Chuck and Gena Norris and their attorneys. No settlement payment was made and each party paid their own costs. 

For more information:


Related Content of MRI Gadolinium Safety Concerns

VIDEO: How Serious is MRI Gadolinium Retention in the Brain and Body? An interview with Max Wintermark, M.D.

VIDEO “Big Concerns Remain for MRI Gadolinium Contrast Safety at RSNA 2017,” An interview with Emanuel Kanal, M.D.

Radiology Has Failed to Properly Assess or Track MRI Gadolinium Contrast Safety

Recent Developments in Contrast Media

FDA Committee Votes to Expand Warning Labels on Gadolinium-Based Contrast Agents

European Medicines Agency Issues Update on Gadolinium Contrast Agents

ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents

FDA: No Harm in MRI Gadolinium Retention in the Brain

VIDEO: MRI Gadolinium Contrast Retention in the Brain

Gadolinium May Remain in Brain After Contrast MRI


Related Content

Electronic cigarette or vaping product use-associated lung injury in a 51-year-old man manifesting as an acute lung injury pattern at CT with subsequent organization.

Electronic cigarette or vaping product use-associated lung injury in a 51-year-old man manifesting as an acute lung injury pattern at CT with subsequent organization. (a, c) Axial unenhanced CT images at presentation through (a) mid and (c) lower lungs show ground-glass opacity with subpleural sparing (arrows); this distribution was present in 45% of chest CT studies at presentation in our cohort (11). (b, d) Axial unenhanced CT images obtained 6 days later show ground-glass opacity has transitioned to consolidation and mild architectural distortion, consistent with developing organization. The patient was initially treated with antibiotics followed by corticosteroid therapy, with slow clinical improvement. Image courtesy of Radiological Society of North America

News | Computed Tomography (CT) | August 27, 2020
August 26, 2020 — Injuries to the lungs from...
The global pediatric imaging market size is expected to reach $12.2 billion by 2027, registering a CAGR of 7.6% over the forecast period, according to a new report by Grand View Research, Inc.

Getty Images

News | Pediatric Imaging | August 26, 2020
August 26, 2020 — The global ...
Change Healthcare acquires industry standard for episode of care definitions used for value-based care plans
News | Radiology Business | August 26, 2020
August 26, 2020 — Change Healthcare announced it has acquired...
Researchers led by Göttingen University develop new three-dimensional imaging technique to visualize tissue damage in severe COVID-19

T Salditt, M Eckermann

Sections through the three-dimensional reconstruction volume (upper left, grey) around a pulmonary alveolus with hyaline membrane (lower left, yellow). On the right, the images are superimposed. In the centre is the air bubble (alveolus). The electron density is represented by different shades of grey. On the inside of the air bubble is a layer of proteins and dead cell residues, the "hyaline membrane". This deposit, which can be represented in its three-dimensional structure for the first time by the new method, reduces the gas exchange and leads to respiratory distress.

News | Coronavirus (COVID-19) | August 25, 2020
August 25, 2020 — Physicists at the University of Göttingen
The above image shows a quantitative rCBV map, automatically generated within the Arterys platform

The above image shows a quantitative rCBV map, automatically generated within the Arterys platform.

News | Artificial Intelligence | August 24, 2020
August 24, 2020 — Imaging Biometrics, LLC, a subsidiar
Acquisition complements Hyland’s platform and rich product portfolio of automation and integration tools

Getty Images

News | Radiology Business | August 21, 2020
August 21, 2020 — Hyland, a leading content services provider, a
Change Healthcare announced the acquisition of, a leader in the development of advanced, fully enabled, cloud-native imaging and workflow technology.
News | Enterprise Imaging | August 21, 2020
August 21, 2020 — Change Healthcare announced the acqui
AI-Rad Companion Prostate MR for Biopsy Support segments prostate for targeted biopsy under MRI and ultrasound fusion imaging

Image courtesy of Clinica Universidad de Navarra, Spain

News | Artificial Intelligence | August 19, 2020
August 19, 2020 — The Food and Drug Administration (FDA) has cleared two additional...